Cargando…

Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis

INTRODUCTION: Allergen immunotherapy (AIT) is the only disease-modifying treatment option available for patients with IgE-mediated allergic rhinitis. The identification of specific biomarkers, which may predict response to AIT, is currently an active field of research in the aspect of recommended pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jura-Szołtys, Edyta, Gawlik, Radosław, Branicka, Olga, Stryjewska-Makuch, Grażyna, Glück, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837575/ https://www.ncbi.nlm.nih.gov/pubmed/36686010 http://dx.doi.org/10.5114/ada.2022.117978

Ejemplares similares

Serum levels of interleukin 33 and its receptor ST2 in patients treated with subcutaneous allergen immunotherapy in intermittent allergic rhinitis
por: Glück, Joanna, et al.
Publicado: (2019)

Phenotypes of Chronic Rhinosinusitis and Peripheral Blood Leukocytes Parameters in Elderly Patients
por: Stryjewska-Makuch, Grażyna, et al.
Publicado: (2023)

Upper Respiratory Tract Diseases in Athletes in Different Sports Disciplines
por: Gałązka-Franta, Anna, et al.
Publicado: (2016)

Individualized Treatment of Allergic Rhinitis According to Nasal Cytology
por: Chen, Jianjun, et al.
Publicado: (2017)

Bronchial asthma control after argon plasma coagulation turbinectomy in patients with chronic rhinitis
por: Jura-Szołtys, Edyta, et al.
Publicado: (2013)

Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
por: Lourenço, Edmir Américo, et al.
Publicado: (2015)

241 Nasal Cytology is Important in the Classification of Patients with Allergic and Non-Allergic Rhinitis
por: Mion, Olavo, et al.
Publicado: (2012)

Local Nasal Specific Immunotherapy for Allergic Rhinitis
por: Passalacqua, Giovanni, et al.
Publicado: (2006)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015)

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018)

Scraping nasal cytology in the diagnostics of rhinitis and the comorbidities
por: Myszkowska, Dorota, et al.
Publicado: (2022)

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis
por: Bozek, Andrzej, et al.
Publicado: (2022)

The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis
por: Gelardi, Matteo, et al.
Publicado: (2018)

Nasal microbes in allergic rhinitis children with or without sublingual immunotherapy
por: Shen, Xiao-Fei, et al.
Publicado: (2023)

Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity
por: Glück, Joanna, et al.
Publicado: (2012)

Administration and burden of subcutaneous immunotherapy for allergic rhinitis in clinical practice in Canada
por: Blume, Steven W, et al.
Publicado: (2014)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis
por: Endaryanto, Anang, et al.
Publicado: (2022)

The relationship between nasal polyps, bronchial asthma, allergic rhinitis, atopic dermatitis, and non-allergic rhinitis
por: Wojas, Oksana, et al.
Publicado: (2021)

Predictive Value of Nasal Nitric Oxide and Serum NOS2 Levels in the Efficacy of Subcutaneous Immunotherapy in Pediatric Patients with Allergic Rhinitis
por: Wen, Sihui, et al.
Publicado: (2022)

Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice
por: Blume, Steven W., et al.
Publicado: (2015)

Microbial characterization of the nasal cavity in patients with allergic rhinitis and non-allergic rhinitis
por: Che, Yanlu, et al.
Publicado: (2023)

Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
por: Huang, Yanran, et al.
Publicado: (2018)

Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients
por: Sousa, Letícia, et al.
Publicado: (2018)

Effects of Serum Vitamin D and Efficacy of Subcutaneous Immunotherapy in Adult Patients With Allergic Rhinitis
por: Joudi, Maryam, et al.
Publicado: (2019)

Interactive Network Platform Improves Compliance and Efficacy of Subcutaneous Immunotherapy for Patients with Allergic Rhinitis
por: Shen, Zhiying, et al.
Publicado: (2019)

Efficacy of subcutaneous immunotherapy for patients with asthma and allergic rhinitis in Korea: effect on eosinophilic inflammation
por: Kim, Chang Keun, et al.
Publicado: (2021)

Nasal hyperreactivity and inflammation in allergic rhinitis
por: Garrelds, I. M., et al.
Publicado: (1996)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Correlation Between SNOT-22, Nasal Cytology, and Mood Disorders in Patients With Allergic Rhinitis Treated With a Liposomal Nasal Spray
por: Lauriello, Maria, et al.
Publicado: (2019)

411 The Classification of Allergic Rhinitis and Its Cytological Correlate
por: Gelardi, Matteo, et al.
Publicado: (2012)

Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
por: Chen, Huan, et al.
Publicado: (2022)

Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost
por: Dranitsaris, George, et al.
Publicado: (2014)

Metabolomics Reveals Process of Allergic Rhinitis Patients with Single- and Double-Species Mite Subcutaneous Immunotherapy
por: Zheng, Peiyan, et al.
Publicado: (2021)

The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis
por: Huang, Jingyu, et al.
Publicado: (2023)

Can development of asthma and bronchial hyperreactivity be reduced by subcutaneous immunotherapy in adult patients with allergic rhinitis?
por: TEPETAM, Fatma Merve, et al.
Publicado: (2023)

Nasal IgE in subjects with allergic and non-allergic rhinitis
por: Eckrich, Jonas, et al.
Publicado: (2020)

Nasal and Exhaled Nitric Oxide in Allergic Rhinitis
por: Lee, Keon Jung, et al.
Publicado: (2012)

Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020)

Immunotherapy in the Treatment of Allergic Rhinitis in Children
por: Alamri, Ruba A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9m8qkse8duhummhj76rcqu50u3